Virpas Tablet Substitute
Mylan Pharmaceuticals Pvt Ltd
₹16000
(₹571.43 per unit)
Zydus Cadila
₹18500
(₹660.71 per unit)
Alkem Laboratories Ltd
₹23940.43
(₹855.02 per unit)
Natco Pharma Ltd
₹25000
(₹892.86 per unit)
Biocon Ltd
₹26000
(₹928.57 per unit)
Torrent Pharmaceuticals Ltd
₹26499
(₹946.39 per unit)
Abbott India Ltd
₹27500
(₹982.14 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Virpas Tablet to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - LEDIPASVIR-90MG+SOFOSBUVIR-400MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Virpas Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection. The detailed uses of Virpas Tablet are as follows:
Virpas Tablet used to treat chronic (long-term) hepatitis C virus infection in adults and children 3 years of age and older. Virpas Tablet contains the active ingredients ledipasvir and sofosbuvir. Ledipasvir and Sofosbuvir work together to prevent the virus from growing and reproducing. Thus, the infection can be completely eliminated from the body.
RX
RX